As part of its drive to reduce the complexity of its Consumer Healthcare (CHC) portfolio, French drugmaker Sanofi has agreed to sell 16 products marketed exclusively in...
05.03.2020
- German generics producer Stada is buying 15 over-the-counter (OTC) consumer healthcare brands from GlaxoSmithKline (GSK), marking its second acquisition of branded products from...
07.11.2019
- In the largest acquisition in the company’s history, German generics producer Stada is paying $660 million to take some of the over-the-counter and prescription drugs portfolio of...
27.09.2017
- In the shifting pharmaceutical landscape, contract manufacturing organizations (CMOs) and big pharma could see significant benefits. The findings of a new A.T. Kearney study can...
29.08.2016
- An extremely bitter proxy battle – rare for Germany – that has rocked generic drugmaker Stada for months culminated in the replacement of supervisory board chairman, Martin Abend...
21.07.2012
- Aggressive consolidation among U.S. and European generic drugmakers is putting pressure on smaller competitors in the industry, whose best hope of surviving a brewing price war may...
30.05.2012
- German generic drugmaker Stada said rivals' growing appetite for takeovers is spurring it to also seek acquisitions as the industry goes for size to cut costs and compete on price...
03.11.2011
- Viiv Healthcare, a GlaxoSmithKline and Pfizer joint venture, will start manufacturing HIV medicines in Russia in partnership with local drugmaker Binnopharm. Agreeing a local...
